Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
- • Biosero signed a framework agreement in August 2025.
- • First purchase orders total 15.2 million dollars.
- • Contract highlights Bico's growth in laboratory automation.
- • Announcement made via press release.
Key details
Biosero, a subsidiary of Bico, has landed a significant framework agreement with a prominent global pharmaceutical company. Announced on September 5, 2025, the deal showcases Biosero's growing footprint in integrated laboratory automation solutions. Initially, this agreement has led to purchase orders aggregating approximately 15.2 million dollars, which is around 143.6 million Swedish kronor. This development signals Bico's capability to attract lucrative contracts within the competitive pharmaceutical industry, reinforcing the importance of its operations in the biotechnology sector.
This article was translated and synthesized from Swedish sources, providing English-speaking readers with local perspectives.
Source articles (1)
Latest news
Swedish Schools Face Challenges in Preventive Health and Teacher Preparedness
Mia Skäringer's 'Mia, myself & I - Sista Måltiden' Premieres to Critical Acclaim for its Intimacy and Humor
Sweden's Data Center Boom: Billion-Euro Projects Meet Environmental Challenges
Rising Trust in Politicians and Youth Engagement Mark Sweden's 2026 Elections
KD Politician Erik Kainulainen Resigns Amid Assault Allegations, Continues as Independent
Sweden's Industrial Employers Urge Lower Wage Increases Amid Rising Chinese Competition
The top news stories in Sweden
Delivered straight to your inbox each morning.